Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome. (Q38375421)
Jump to navigation
Jump to search
scientific article published on 27 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome. |
scientific article published on 27 February 2010 |
Statements
Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome (English)
Jean-Claude Tardif
Philippe L L'allier
Jean C Grégoire
Anna Nozza
Mariève Cossette
Simon Kouz
Marc-André Lavoie
Janie Paquin
Rebecca Taub
Josephine Pressacco
27 February 2010